Combination of cetuximab with radio-chemotherapy in patients with esophageal cancer: less is more!

od Hofheinz, Ralf-Dieter, Kripp, Melanie, Lorenzen, Sylvie
Izdano u J Thorac Dis (2015)

Risk of Confusion: Detection of a Circular Thickness of the Wall in the Lower Part of the Esophagus

od Hochlehnert, Achim, Lorenzen, Sylvie, Hallscheidt, Peter, Encke, Jens, Ehehalt, Robert
Izdano u Gastroenterology Res (2011)

Immunotherapy: New Options in Gastrointestinal Cancers?

od Tannapfel, Andrea, Reinacher-Schick, Anke, Hacker, Ulrich, Lorenzen, Sylvie, Möhler, Markus, Vogel, Arndt
Izdano u Visc Med (2019)

(18)F-Fluromisonidazole PET Imaging as a Biomarker for the Response to 5,6-Dimethylxanthenone-4-Acetic Acid in Colorectal Xenograft Tumors

od Oehler, Christoph, O’Donoghue, Joseph A., Russell, James, Zanzonico, Pat, Lorenzen, Sylvie, Ling, C. Clifton, Carlin, Sean
Izdano 2011

Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell Carcinoma

od Janmaat, Vincent T., Bruno, Marco J., Polinder, Suzanne, Lorenzen, Sylvie, Lordick, Florian, Peppelenbosch, Maikel P., Spaander, Manon C. W.
Izdano u PLoS One (2016)

Significance of tumour regression in lymph node metastases of gastric and gastro‐oesophageal junction adenocarcinomas

od Reim, Daniel, Novotny, Alexander, Friess, Helmut, Slotta‐Huspenina, Julia, Weichert, Wilko, Ott, Katja, Dislich, Bastian, Lorenzen, Sylvie, Becker, Karen, Langer, Rupert
Izdano u J Pathol Clin Res (2020)

RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomi...

od Lorenzen, Sylvie, Biederstädt, Alexander, Ronellenfitsch, Ulrich, Reißfelder, Christoph, Mönig, Stefan, Wenz, Frederik, Pauligk, Claudia, Walker, Martin, Al-Batran, Salah-Eddin, Haller, Bernhard, Hofheinz, Ralf-Dieter
Izdano u BMC Cancer (2020)

Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): The Heidelberg Imaging program in Cancer of the oesophago-...

od Lorenzen, Sylvie, von Gall, Carl, Stange, Annika, Haag, Georg M, Weitz, Jürgen, Haberkorn, Uwe, Lordick, Florian, Weichert, Wilko, Abel, Ulrich, Debus, Jürgen, Jäger, Dirk, Münter, Marc W
Izdano 2011

Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis

od Metz, Stephan, Ganter, Carl, Lorenzen, Sylvie, van Marwick, Sandra, Holzapfel, Konstantin, Herrmann, Ken, Rummeny, Ernst J., Wester, Hans-Jürgen, Schwaiger, Markus, Nekolla, Stephan G., Beer, Ambros J.
Izdano u PLoS One (2015)

High-Grade Osteosarcoma of the Foot: Presentation, Treatment, Prognostic Factors, and Outcome of 23 Cooperative Osteosarcoma Study Group COSS Patients

od Schuster, Anne J., Kager, Leo, Reichardt, Peter, Baumhoer, Daniel, Csóka, Monika, Hecker-Nolting, Stefanie, Lang, Susanna, Lorenzen, Sylvie, Mayer-Steinacker, Regine, von Kalle, Thekla, Kevric, Matthias, Werner, Mathias, Windhager, Reinhard, Wirth, Thomas, Bielack, Stefan S.
Izdano u Sarcoma (2018)

Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of...

od Luber, Birgit, Deplazes, Joëlle, Keller, Gisela, Walch, Axel, Rauser, Sandra, Eichmann, Martin, Langer, Rupert, Höfler, Heinz, Hegewisch-Becker, Susanna, Folprecht, Gunnar, Wöll, Ewald, Decker, Thomas, Endlicher, Esther, Lorenzen, Sylvie, Fend, Falko, Peschel, Christian, Lordick, Florian
Izdano 2011

HER2 testing in gastric cancer: results of a German expert meeting

od Lordick, Florian, Al-Batran, Salah-Eddin, Dietel, Manfred, Gaiser, Timo, Hofheinz, Ralf-Dieter, Kirchner, Thomas, Kreipe, Hans H., Lorenzen, Sylvie, Möhler, Markus, Quaas, Alexander, Röcken, Christoph, Rüschoff, Josef, Tannapfel, Andrea, Thuss-Patience, Peter, Baretton, Gustavo
Izdano u J Cancer Res Clin Oncol (2017)

Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INT...

od Tintelnot, Joseph, Goekkurt, Eray, Binder, Mascha, Thuss-Patience, Peter, Lorenzen, Sylvie, Knorrenschild, Jorge Riera, Kretzschmar, Albrecht, Ettrich, Thomas, Lindig, Udo, Jacobasch, Lutz, Pink, Daniel, Al-Batran, Salah-Eddin, Hinke, Axel, Hegewisch-Becker, Susanna, Nilsson, Sven, Bokemeyer, Carsten, Stein, Alexander
Izdano u BMC Cancer (2020)

Evaluation of EGFR inhibitor‐mediated acneiform skin toxicity within the double‐blind randomized EVITA trial: A thorough gender‐specific analysis using the WoMo score

od Gaiser, Maria R., Lorenzen, Sylvie, Merx, Kirsten, Trojan, Jörg, Ocvirk, Janja, Ettrich, Thomas J., Al‐Batran, Salah‐Eddin, Schulz, Holger, Homann, Nils, Feustel, Hans‐Peter, Schatz, Michael, Kripp, Melanie, Schulte, Nadine, Heeger, Steffen, Vlassak, Soetkin, Koch, Winfried, Hofheinz, Ralf‐Dieter
Izdano u Cancer Med (2019)

Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer: A...

od Cortés, Javier, Diéras, Véronique, Lorenzen, Sylvie, Montemurro, Filippo, Riera-Knorrenschild, Jorge, Thuss-Patience, Peter, Allegrini, Giacomo, De Laurentiis, Michelino, Lohrisch, Caroline, Oravcová, Eva, Perez-Garcia, Jose M., Ricci, Francesco, Sakaeva, Dina, Serpanchy, Rosanne, Šufliarský, Jozef, Vidal, Maria, Irahara, Natsumi, Wohlfarth, Christine, Aout, Mounir, Gelmon, Karen
Izdano u JAMA Oncol (2020)

PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer

od Stein, Alexander, Simnica, Donjete, Schultheiß, Christoph, Scholz, Rebekka, Tintelnot, Joseph, Gökkurt, Eray, von Wenserski, Lisa, Willscher, Edith, Paschold, Lisa, Sauer, Markus, Lorenzen, Sylvie, Riera-Knorrenschild, Jorge, Depenbusch, Reinhard, Ettrich, Thomas J, Dörfel, Steffen, Al-Batran, Salah-Eddin, Karthaus, Meinolf, Pelzer, Uwe, Waberer, Lisa, Hinke, Axel, Bauer, Marcus, Massa, Chiara, Seliger, Barbara, Wickenhauser, Claudia, Bokemeyer, Carsten, Hegewisch-Becker, Susanna, Binder, Mascha
Izdano u J Immunother Cancer (2021)

The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic...

od Al-Batran, Salah-Eddin, Goetze, Thorsten O., Mueller, Daniel W., Vogel, Arndt, Winkler, Michael, Lorenzen, Sylvie, Novotny, Alexander, Pauligk, Claudia, Homann, Nils, Jungbluth, Thomas, Reissfelder, Christoph, Caca, Karel, Retter, Steffen, Horndasch, Eva, Gumpp, Julia, Bolling, Claus, Fuchs, Karl-Hermann, Blau, Wolfgang, Padberg, Winfried, Pohl, Michael, Wunsch, Andreas, Michl, Patrick, Mannes, Frank, Schwarzbach, Matthias, Schmalenberg, Harald, Hohaus, Michael, Scholz, Christian, Benckert, Christoph, Knorrenschild, Jorge Riera, Kanngießer, Veit, Zander, Thomas, Alakus, Hakan, Hofheinz, Ralf-Dieter, Roedel, Claus, Shah, Manish A., Sasako, Mitsuru, Lorenz, Dietmar, Izbicki, Jakob, Bechstein, Wolf O., Lang, Hauke, Moenig, Stefan P.
Izdano u BMC Cancer (2017)